There's a massive economic incentive here for them and Moderna to keep this Gravy train rolling. Maybe we need to find a different way of Using emergency use authorization in the future. We are pushing the boundaries of science and the body is still very poorly understood And so the sensitivity and specificity of these drugs may not be what we think upfront.